Genetic Epidemiology of Chronic Lymphocytic Leukemia Consortium (GEC)
Purpose of the study
Because CLL exhibits one of the strongest familial tendencies of any lymphoproliferative disorders (LPD), we have focused this project to specifically investigate the genetic basis of CLL through the use of high-risk CLL families. To do this, we have formed a multi-center, multidisciplinary consortium, entitled the Genetic Epidemiology of CLL (GEC) Consortium. The GEC Consortium is funded by the National Cancer Institute (U01 CA 118444) and includes investigators from Mayo Clinic, M.D. Anderson Cancer Center, National Cancer Institute, University of California in San Diego, University of Minnesota, Duke University, and the University of Utah. This family-based research resource allows us to develop a study population enriched for genetic exposures and will position us to characterize the genetic risk of CLL.
Who is eligible to participate in this study?
An eligible CLL family has at least the following two characteristics:
What is involved in the study?
To participate, you do not need to travel to Mayo Clinic or any of the CLL Consortium sites. Participation includes:
Who do I contact to participate in the study?
If you wish to obtain more information or to participate in our study please call:
Patients do not need to actually visit these sites to participate. Further, our program will pay for any costs associated with participation in the study.
© 2013 Mayo Foundation for Medical Education and Research. All rights reserved.